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Abstract 
 BACKGROUND: Stroke is a leading cause of death and long-term disability worldwide. 
Although a minority of ischemic strokes in the community affect younger adults, up to 40% of 
acute ischemic strokes in young adults are cryptogenic in nature, that is, no cause is determined. 
Underlying pathologies of stroke of unknown cause are multiple, including patent foramen ovale 
(PFO). The PFO is the most common defect of atrial septum of the heart. This study evaluated 
the frequency of PFO in brain stroke with unknown etiology in patients younger than 50 years of 
age in Kerman. 
 METHODS: This cross-sectional study was done in Shafa Medical Center of Kerman University 
of Medical Sciences in 2008. For detection of the PFO, we used agitated saline test with 
transcranial Doppler sonography in brain stroke patients with unknown etiology and also a 
control group (normal persons). 
 RESULTS: PFO was found in 53% of patients. No significant difference was observed between 
sexes. The rate in the control group was 20%. Patients with large PFO had 2 or more attacks of 
stroke. Subjects in the control group did not have large PFO. 
 CONCLUSION: One of the most important underlying causes in young adults with cryptogenic 
stroke is PFO. It is better to prescribe antiplatelet drugs in patients with the first attack of 
stroke, but as for patients with recurrent stroke, closure of PFO must be considered. 
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Introduction 
Stroke is a leading cause of death and long-term 
disability worldwide. Eighty-five percent of strokes 
are ischemic, and most of the ischemic strokes occur 
in persons older than 65 years of age in tandem with 
the development of atherosclerosis. However, 
minorities of ischemic strokes in the community 
affect younger adults.1  
 The risks of recurrent vascular events in young 
adults who have had ischemic stroke is considerable. 
In addition, a majority of survivors will have residual 
emotional, social or physical impairments that hamper 
employment or lower their quality of life.2 
 Underlying pathologies of stroke of unknown 
cause include atherosclerosis in brain arteries 
(although it may not be related to the current stroke). 
Cardiac findings in a stroke patient may not be related 
to current stroke (e.g. patent foramen ovale). If the 
workup for stroke cause is done incompletely or late, 
it may not find the responsible cause of stroke (e.g. 
arterial dissection, mobile intracardiac/luminal 
thrombus disappeared at the time of examination).3  
 The patent foramen oval (PFO) is the most 
common defect of atrial septum of the heart.4 The 
cause of stroke in a patient with PFO is presumed to 
be paradoxical embolism, unless there is actual 
visualization of an entrapped thrombus through the 
PFO.5-10 One of the other underlying causes is 
premature atrial contraction. It has been reported that 
the frequency of premature atrial contraction is more 
common in patients with stroke of undetermined 
etiology in which non-cardiac emboli was thought to 
be the cause of stroke.6 It has also been reported that 
polymorphism in the C5 gene is associated with the 
risk of ischemic stroke.7 Using current clinical criteria, 
30% of strokes and transient ischemic attacks have 
been shown to be of undetermined etiology. Gene 
regulations can cause large vessel atherosclerotic 
strokes through altering the activity of platelets and 
monocytes and hemoestasis. Gene regulations are 
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effective in cardiac-emboli strokes through neutrophil 
and modulated immune responses to infectious stimuli.8 
 About 15-20% of cases of brain infarctions occur 
in patients under the age of 55. Although over 150 
causes of stroke have been listed, a thorough 
evaluation showed that the causes of stroke remain 
unknown in up to 50-60% of cases in patients 
younger than 55 years of age11 and some other studies 
found this rate to be 40%.9 In this study we evaluated 
the frequency of PFO in brain stroke with unknown 
etiology in patients younger than 50 years old. 
Materials and Methods 
This cross-sectional study was done in Shafa Medical 
Center of Kerman University of Medical Sciences in 
2008. All stroke patients less than 50 years old of age 
that referred to neurology department were evaluated. 
The patients with one of the following items were 
excluded: valvular heart diseases, cardiomyopathy, 
coronary artery disease, anemia and hematologic 
disorders, cardiac arrhythmia, vasculitis, malignancy, 
abnormal transcranial Doppler sonography (TCD) of 
carotids, dissections, contraceptive drugs intake and 
migraine with aura. The control group has been 
selected from normal persons (without a history of 
exclusion criteria and stroke).  
 The transcranial Doppler sonogram device was 
joined with DWL 2.5 X2 software box made in 
Germany. For detection of blood flow in middle 
cerebral artery (MCA) a 2MHZ probe was used. 
TCD is a sensitive detector of right-to-left shunt.12-14 
 At first we prepared a questionnaire including age, 
sex, clinical findings, past history of stroke, results of 
imaging (brain CT scan or MRI scan) and results of 
agitated saline contrast test with TCD findings.  
 While the patients lay on TCD bed, the probe was 
fixed on the temporal window for MCA blood flow 
detection. Ten milliliters of contrast fluid (9 milliliters 
of normal saline, 0.5 milliliter of patient's blood 
sample and 0.5 milliliter air) was shaken well until a 
homogenous fluid was produced. Then, we took an 
intravenous line by a number 20 angiocatheter on 
brachial vein. After checking the MCA blood flow, 
the contrast fluid was injected (for 10 seconds), and 
the monitor graphs were saved for 10 seconds, and 
then the test was repeated with Valsalva maneuver 
(VM). The increase of VM expiratory pressure 
magnifies the number of microbubbles irrespective of 
the strain duration. Since the right-to-left shunt 
classification in PFO is based on the number of 
microbubbles,15 if microbubbles were not detected, 
the test was repeated after 5 minutes. The number of 
microbubble clicks of monitor graphs was detected. If 
the number of clicks were more than 10, the PFO 
was considered large and if they were lower than 10, it 
was considered small.16 For all the patients and the 
control group with PFO, we performed 
transesophageal echocardiogram without contrast. 
Only in one of the patients, the PFO wasn’t seen. 
Results 
This cross-sectional study has been done on 30 cases 
of stroke under the age of 50 with unknown etiology 
and 30 normal persons (control group) using agitated 
normal saline test with TCD.   
 Table 1 shows the distribution of sex and age of 
patients, along with the rate of PFO. In the control 
group the rate of PFO was 20% (6 cases). 
 There was a significant difference in PFO rate (P 
= 0.01) between the patients and the control group. 
However, no significant difference was observed in 
terms of sex and the rate of PFO (P = 0.6) among the 
patients and the control group. Distribution of age 
showed that most patients were between 25-45 years 
old. No significant difference existed between the age 
groups of 26-35 and 36-45 (P = 1).  
 
Table 1. Distribution of age and sex in patients with and without PFO 
  Age groups n(% within Age) Total 
  15-25 26-35 36-45 46-50  
PFO+ female 1(100.0) 4(57.1) 3(50.0) 1(50.0) 9(56.3) 
 male 0(.0) 3(42.9) 3(50.0) 1(50.0) 7(43.8) 
 Total 1(100.0) 7(100.0) 6(100.0) 2(100.0) 16(100.0) 
PFO- female 2(50.0) 3(75.0) 2(66.7) 1(33.3) 8(57.1) 
 male 2(50.0) 1(25.0) 1(33.3) 2(66.7) 6(42.9) 
 Total 4(100.0) 4(100.0) 3(100.0) 3(100.0) 14(100.0) 
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 Three patients had large PFO but two of them 
had more than two attacks of stroke. Fourteen 
patients with PFO had infarction in MCA domain, 
and two patients had strokes in posterior circulation 
domain (there isn’t a significant difference between 
two groups). 
Discussion 
This study found that the rate of PFO was more than 
53% in brain stroke with unknown etiology 
(cryptogenic), but in control group this rate is 20%. 
This finding is similar to other reports. There is an 
association between the presence of PFO and 
cryptogenic stroke in both old patients and young 
patients.17 The most prevalent potential source of 
cardioembolism in young adults with cryptogenic 
stroke is PFO, which is detected in more than half of 
such persons undergoing evaluation.18-23  
 In normal persons, the rate of PFO was 20% 
which is in agreement with the results of many other 
reports. In an autopsy study of 965 normal hearts 
from patients with no history of cardioembolic 
events, the prevalence of PFO was 27%, and in some 
reports there was no difference between men and 
women, regardless of age.24-26  
 In addition, a recent prospective study found a 
significantly (P < 0.02) higher prevalence of PFO in 
patients with cryptogenic stroke compared with 
patients with stroke of known cause.27 In a study, a 
shunt was found in 20% of stroke patients with 
known etiology and 50% of unknown etiology.28  
 The rate of PFO in two groups of age (26-35 and 
36-45 years) did not reveal any significant differences. 
Interestingly though, in the lowest age group (< 55 
years), the incidence of recurrent stroke or death 
tended to be lower in patients with a PFO, and it 
was about equal among people aging 55 to 65. 
However, subjects with 65-80s of age were 3 times 
more likely to have a stroke or death if a PFO was 
present, even after adjustment for other 
cardiovascular risk factors. As one gets older, he 
probably has more venous emboli and his right atrial 
pressure goes up, raising the risk of PFO-mediated 
embolic events to the point where, in the elderly, 
that risk may be just as important as the underlying 
atherosclerotic disease.29  
 A study conducted on general population showed 
that the PFO, alone or together with atrial septal 
aneurism, was not associated with an increased stroke 
risk in this multiethnic cohort.30 
 In our study, the patients with large PFO had 
more stroke attacks which is similar to other studies. 
However, a study with a longer period is suggested. 
The amount of shunting was the only significant 
independent variable associated with relapse, i.e. at 
the end of the follow-up period, the recurrence rate 
was 0.66% and 8.2% per patient per year in patients 
with small and large shunt, respectively. In patients 
with PFO-related stroke, the amount of right-to-left 
shunt as assessed with TCD is the only independent 
predictor of relapse. Therefore, PFO sizing is 
mandatory in patients with PFO.16 Interestingly, in 
our study, the PFOs in control group were all small. 
The association of PFO with other disorders, 
especially migraine with aura, must be taken into 
consideration. In a study, the rate of PFO in migraine 
headache with aura was 40%,31 but our patients didn’t 
have migraine headaches with aura. 
Conclusion 
One of the most important underlying causes in young 
adults with cryptogenic stroke is PFO. In patients with 
the first attack of stroke it is better to prescribe 
antiplatelet drugs, but as for patients with recurrent 
stroke, closure of PFO must be considered. 
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